Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by ANALIAS00on Feb 04, 2021 5:33pm
117 Views
Post# 32479426

RE:TH would be double the current SP today if the oxygen had

RE:TH would be double the current SP today if the oxygen hadI fully agree and this is what FTV do not get. As long as TH do not provide the details that justified that deal and the bad timing, everyone that knows a little bit about stocks can only qualify the deal as horrible and bad fore long shareolders (and for TH to) EVEN if SP reach 4 or 5 or 30$ (which wont happen Fred so dont hold your breath). But hang on Fred, one day you will be right on something. :o) I will be tje first to congradulate you :o)
palinc2000 wrote: not been taken out of the momentum on January 11 IMO,,,We will get there by spring time but the scars of the bad deal will  get even deeper as the upward momentum resumes,,,


<< Previous
Bullboard Posts
Next >>